We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS
Read MoreHide Full Article
The upcoming report from Sabra Healthcare (SBRA - Free Report) is expected to reveal quarterly earnings of $0.34 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $163.67 million, representing an increase of 1.5% year over year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Sabra metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts predict that the 'Revenues- Interest and other income' will reach $8.95 million. The estimate indicates a year-over-year change of +2.5%.
The average prediction of analysts places 'Revenues- Resident fees and services' at $62.48 million. The estimate points to a change of +10.2% from the year-ago quarter.
It is projected by analysts that the 'Revenues- Rental and related revenues' will reach $94.43 million. The estimate indicates a change of -1.5% from the prior-year quarter.
The combined assessment of analysts suggests that 'Depreciation and amortization' will likely reach $43.34 million. Compared to the current estimate, the company reported $52.83 million in the same quarter of the previous year.
Shares of Sabra have experienced a change of -0.9% in the past month compared to the -1.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), SBRA is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Exploring Analyst Estimates for Sabra (SBRA) Q1 Earnings, Beyond Revenue and EPS
The upcoming report from Sabra Healthcare (SBRA - Free Report) is expected to reveal quarterly earnings of $0.34 per share, indicating no change from the year-ago quarter compared to the year-ago period. Analysts forecast revenues of $163.67 million, representing an increase of 1.5% year over year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
With that in mind, let's delve into the average projections of some Sabra metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts predict that the 'Revenues- Interest and other income' will reach $8.95 million. The estimate indicates a year-over-year change of +2.5%.
The average prediction of analysts places 'Revenues- Resident fees and services' at $62.48 million. The estimate points to a change of +10.2% from the year-ago quarter.
It is projected by analysts that the 'Revenues- Rental and related revenues' will reach $94.43 million. The estimate indicates a change of -1.5% from the prior-year quarter.
The combined assessment of analysts suggests that 'Depreciation and amortization' will likely reach $43.34 million. Compared to the current estimate, the company reported $52.83 million in the same quarter of the previous year.
View all Key Company Metrics for Sabra here>>>
Shares of Sabra have experienced a change of -0.9% in the past month compared to the -1.6% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), SBRA is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>